Moderna begins phase 3 clinical trial of combo flu, COVID vaccine

Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccine Moderna announced the first participant has been dosed in the company's phase 3 clinical trial of its combination flu and COVID vaccine. ABC News ABC News

...

In a press release, the biopharmaceutical company said the combination vaccine has "the potential to efficiently reduce the overall burden of acute viral respiratory disease" by giving simultaneous protection against flu and COVID in a single dose.

...